Amicus Therapeutics Inc. buy BiotechBee
Start price
13.01.23
/
50%
€11.78
Target price
31.05.24
€17.00
Performance (%)
-9.18%
End price
05.05.23
€10.70
Summary
This prediction ended on 05.05.23 with a price of €10.70. With a performance of -9.18%, the BUY prediction by BiotechBee finished with a loss. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Amicus Therapeutics Inc. | -0.833% | -0.833% | 30.769% | 2.427% |
| iShares Core DAX® | 1,93 % | -2,11 % | 11,14 % | 59,64 % |
| iShares Nasdaq 100 | -0,18 % | -5,90 % | -0,15 % | 82,45 % |
| iShares Nikkei 225® | 7,08 % | 6,46 % | 28,83 % | 59,33 % |
| iShares S&P 500 | -0,20 % | -3,67 % | -0,10 % | 55,65 % |
According to BiotechBee what are the pros and cons of Amicus Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year